
# translation_dictionary.py

# Common DHF Terms
COMMON_TERMS = {
    "文件编号": "Document Number",
    "版本号": "Version",
    "编写": "Prepared by",
    "受控日期": "Effective Date",
    "编制": "Prepared by",
    "编制人": "Prepared by",
    "签字": "Signature",
    "日期": "Date",
    "部门": "Department",
    "审核": "Reviewed by",
    "审核人": "Reviewed by",
    "批准": "Approved by",
    "批准人": "Approved by",
    "质量部": "Quality Department (QA/QC)",
    "研发部": "R&D Department",
    "法规注册部": "Regulatory Affairs (RA)",
    "市场销售部": "Business Development (BD)",
    "生产部": "Production Department",
    "修订记录": "Revision History",
    "版本": "Version",
    "修订日期": "Revision Date",
    "修订内容": "Description of Change",
    "修订者": "Reviser",
    "新文件": "New Document",
    "产品简介": "Product Introduction",
    "产品名称及型号": "Product Name and Model",
    "产品名称": "Product Name",
    "产品型号": "Model Number",
    "产品规格": "Specifications",
    "预期用途及适用人群用途": "Intended Use and Target Population",
    "预期用途": "Intended Use",
    "适用人群": "Target Population",
    "风险管理范围": "Risk Management Scope",
    "风险管理流程": "Risk Management Process",
    "计划的风险管理活动": "Planned Risk Management Activities",
    "职责和权限的分配": "Roles and Responsibilities",
    "管理代表": "Management Representative",
    "项目负责人员": "Project Manager",
    "市场销售": "Business Development",
    "法规/注册": "Regulatory Affairs",
    "风险可接受标准": "Risk Acceptance Criteria",
    "风险的严重度水平分级": "Severity Level Classification",
    "风险的概率等级": "Probability Level Classification",
    "风险的可接受性准则": "Risk Acceptability Matrix",
    "风险分析": "Risk Analysis",
    "目的": "Purpose",
    "风险管理方法": "Risk Management Methodology",
    "信息收集与生命周期阶段": "Information Collection and Lifecycle Phases",
    "总体剩余风险": "Overall Residual Risk",
    "风险控制措施实施及有效性验证": "Implementation and Verification of Risk Control Measures",
    "上市后产品资讯收集及审查": "Post-Market Surveillance (PMS)",
    "附录": "Appendix",
    "自动注射笔": "Auto-Injector",
    "严重度": "Severity",
    "发生度": "Occurrence",
    "探测度": "Detection",
    "等级名称": "Level Name",
    "代号": "Code",
    "定义": "Definition",
    "频次": "Frequency",
    "每年": "Per Year",
    "灾难性的": "Catastrophic",
    "危重的": "Critical",
    "严重": "Serious",
    "轻度": "Minor",
    "可忽略": "Negligible",
    "经常": "Frequent",
    "有时": "Probable",
    "偶尔": "Occasional",
    "很少": "Remote",
    "非常少": "Improbable",
    "文件": "Document",
    "页码": "Page",
    "第": "Page",
    "页": "",
    "共": "of",
    "活动内容": "Activity",
    "评价要点": "Evaluation Points",
    "交付结果": "Deliverables",
    "责任部门": "Responsible Dept.",
    "完成时限": "Timeline",
    "自动注射笔风险管理计划覆盖生命周期的所有阶段，包括设计开发策划、设计开发、设计改念、模型、临床前期评估、临床评估、制造、销售、使用、售后服务和报废处置。": "The Auto-Injector Risk Management Plan covers all phases of the life cycle, including design and development planning, design and development, design concept, modeling, pre-clinical evaluation, clinical evaluation, manufacturing, sales, usage, after-sales service, and disposal.",
    "用于搭配肾上腺素注射液（预充式）": "Intended for use with Epinephrine Injection (Pre-filled)",
    "进行药液传输（肌肉注射）。仅供单个患者或个人单次使用": "for drug delivery (intramuscular injection). For single patient or single use only.",
    "的患者": "Patients",
    "体重大于等于": "Body weight >= ",
    "体重为": "Body weight is ",
    "根据ISO14971:2019图1Summed建立并维护了有效的": "According to ISO 14971:2019 Figure 1, Summed has established and maintains an effective ",
    "如下所示": "as shown below",
    "执行风险管理活动/任务的人员将具备与分配给他们的这些活动/任务相适应的教育、培训、技能和经验的能力。这些人员应具备特定（或类似）医疗器材及其使用、所涉及的技术或所采用的风险管理技术的知识和经验。下表总结了本次风险管理的人员和知识/经验。": "Personnel performing risk management activities/tasks shall have the capability in education, training, skills, and experience appropriate to those activities/tasks assigned to them. These personnel shall have knowledge and experience of the specific (or similar) medical device and its use, the technologies involved, or the risk management techniques employed. The table below summarizes the personnel and knowledge/experience for this risk management.",
    "负责协调风险管理活动中所需资源。": "Responsible for coordinating resources required for risk management activities.",
    "负责主导产品生命周期全过程的风险管理。具体包括:1.制定上市前和上市后风险管理计划;2.收集风险输入;3.主导初步危害分析;": "Responsible for leading risk management throughout the product lifecycle. Specifically includes: 1. Establishing pre-market and post-market risk management plans; 2. Collecting risk inputs; 3. Leading preliminary hazard analysis;",
    "编写PHA报告和风险管理报告;5.参与DMFEA、PFMEA、UFMEA讨论,并审批风险管理文档;6.组织上市前风险管理评审;7.主导上市后风险管理。": "4. Preparing PHA reports and risk management reports; 5. Participating in DFMEA, PFMEA, UFMEA discussions and approving risk management documents; 6. Organizing pre-market risk management reviews; 7. Leading post-market risk management.",
    "1.负责主导PFMEA讨论,编写PFMEA报告;2.参与PHA、DFMEA、UFMEA、风险管理报告讨论和风险管理评审;审核风险管理文档。3.生产过程的异常反馈及改进、产品危害的确认": "1. Lead PFMEA discussions and write PFMEA reports; 2. Participate in PHA, DFMEA, UFMEA, Risk Management Report discussions and reviews; Review risk management documents. 3. Feedback and improvement of production process anomalies, confirmation of product hazards.",
    "1.负责主导UFMEA讨论,编写UFMEA报告;2.参与PHA、DFMEA、PFMEA、风险管理报告讨论和风险管理评审。3.审批风险管理文档。": "1. Lead UFMEA discussions and write UFMEA reports; 2. Participate in PHA, DFMEA, PFMEA, Risk Management Report discussions and reviews. 3. Approve risk management documents.",
    "参与PHA、DFMEA、PFMEA、UFMEA和风险管理报告的讨论和风险管理评审,并审批风险管理文档。": "Participate in discussions and reviews of PHA, DFMEA, PFMEA, UFMEA, and Risk Management Reports, and approve risk management documents.",
    "导致患者死亡": "Results in patient death",
    "导致永久性损伤或危及生命的伤害": "Results in permanent impairment or life-threatening injury",
    "导致要求专业医疗介入的伤害或损伤": "Results in injury or impairment requiring professional medical intervention",
    "导致不要求专业医疗介入的伤害或损伤": "Results in injury or impairment not requiring professional medical intervention",
    "不便或暂时不适": "Inconvenience or temporary discomfort",
    "注：": "Note: ",
    "是指每台设备": "refers to each device ",
    "发生或预期发生的事件次数": "number of events occurring or expected to occur ",
    "说明：": "Legend: ",
    "可接受的风险": "Acceptable Risk",
    "合理可行降低的风险": "ALARP (As Low As Reasonably Practicable)",
    "不可接受的风险": "Unacceptable Risk",
    "每个风险级别的可接受风险": "The acceptable risk for each risk level ",
    "应低于3": "should be less than 3 ",
    "对于我们的产品而言是可接受的": "is acceptable for our product",
    "应低于9": "should be less than 9 ",
    "对于我们的产品而言是合理可行降低的风险": "is ALARP for our product",
    "换句话说，风险水平高于10，风险是不可接受的。如果不能通过切实可行的风险控制将风险尽可能地降低到可接受范围，我们需要确认收益是否超过风险。": "In other words, if the risk level is higher than 10, the risk is unacceptable. If the risk cannot be reduced to an acceptable range through practicable risk control measures, we need to confirm if the benefits outweigh the risks.",
    "系统性地识别与医疗器械相关的已知和可预见的风险。": "Systematically identify known and foreseeable risks associated with the medical device.",
    "采用1-5分制对每一项失效模式的": "Use a 1-5 scale for each failure mode's ",
    "进行评分，并计算风险优先数": "to score, and calculate the Risk Priority Number ",
    "RPN ≥ 27：必须采取风险降低措施": "RPN >= 27: Risk reduction measures must be taken",
    "RPN<27：可视情况优化，非强制": "RPN < 27: Optimization optional, not mandatory",
    "应基于以下各生命周期阶段收集的定性和定量信息": "should be based on qualitative and quantitative information collected in the following lifecycle phases",
    "生命周期阶段": "Lifecycle Phase",
    "需收集的信息与活动（": "Information/Activities to Collect (",
    "输入）": "Input)",
    "信息/数据来源": "Information/Data Source",
    "概念与设计输入": "Concept and Design Input",
    "预期用途、性能要求、用户特征（年龄、能力、教育程度）、使用环境": "Intended Use, Performance Requirements, User Characteristics (Age, Ability, Education), Use Environment",
    "适用的法规、标准和科学文献": "Applicable Regulations, Standards, and Scientific Literature",
    "产品需求规": "Product Requirements",
    "设计与开发": "Design and Development",
    "设计图纸、材料选择、工作原理分析": "Design Drawings, Material Selection, Working Principle Analysis",
    "初步危害分析（PHA）：基于设计概念识别重大危害": "Preliminary Hazard Analysis (PHA): Identify major hazards based on design concept",
    "设计FMEA：分析组件、子系统和系统的潜在故障模式": "Design FMEA: Analyze potential failure modes of components, subsystems, and systems",
    "可用性工程文件：用户界面、任务分析、已知的使用错误": "Usability Engineering File: User Interface, Task Analysis, Known Use Errors",
    "设计评审": "Design Review",
    "报告": "Report",
    "生产与制造": "Production and Manufacturing",
    "过程验证方案与报告": "Process Validation Plan and Report",
    "在线质量控制数据（如剂量精度测试、功能测试）": "In-process QC Data (e.g. Dose Accuracy Test, Functional Test)",
    "产品标识与可追溯性记录": "Product Identification and Traceability Records",
    "过程FMEA（pFMEA）：分析生产过程可能引入的缺陷": "Process FMEA (pFMEA): Analyze defects potentially introduced by the production process",
    "验证报告": "Validation Report",
    "检验记录、统计过程控制（SPC）数据": "Inspection Records, SPC Data",
    "包装、运输与储存": "Packaging, Transport, and Storage",
    "包装验证报告（模拟运输、跌落、振动测试）": "Packaging Validation Report (Simulation Transport, Drop, Vibration Test)",
    "储存条件稳定性数据": "Storage Stability Data",
    "包装验证协议与报告": "Packaging Validation Protocol and Report",
    "实时/加速老化研究报告": "Real-time/Accelerated Aging Study Report",
    "上市后阶段": "Post-Market Phase",
    "不良事件报告与趋势分析": "Adverse Event Reports and Trend Analysis",
    "售后服务数据（维修、咨询）": "After-sales Service Data (Repair, Inquiry)",
    "不良事件监测数据库（如EUDAMED）": "Adverse Event Monitoring Database (e.g. EUDAMED)",
    "评估整体残留风险的方法和整体残留风险的风险可接受性标准在所有风险控制措施实施并验证后，将评估医疗器材造成的整体残留风险，考虑到所有风险的贡献残余风险。": "After all risk control measures are implemented and verified, the overall residual risk posed by the medical device will be evaluated, considering the contribution of all residual risks.",
    "如果相对于": "If relative to ",
    "的益处，整体残余风险被认为不可接受，将考虑实施额外的风险。": "benefits, the overall residual risk is considered unacceptable, additional risk control measures shall be considered.",
    "险控制措施或修改医疗器材或其": "measures or modification of the device or its ",
    "我们的医疗器械应该完全满足整体残余风险的可接受性标准。": "Our medical device should fully meet the acceptance criteria for overall residual risk.",
    "整体残余风险的可接受性标准将由具有应用知识和临床专业知识的专家来判断。": "The acceptance criteria for overall residual risk will be judged by experts with application knowledge and clinical expertise.",
    "为了": "In order to ",
    "整体剩余风险的可接受性标准，我们应该考虑以下几个输入和考虑因素：": "the acceptance criteria for overall residual risk, we should consider the following inputs and factors:",
    "不同的事件顺序可能导致不同的危险状况和风险。": "Different sequences of events may lead to different hazardous situations and risks.",
    "不同的危险状况可能产生特定的危害。": "Different hazardous situations may produce specific harms.",
    "适用于独立个体风险的风险控制措施可能会导致要求相互冲突，从而增加整体剩余风险。": "Risk control measures applicable to individual risks may lead to conflicting requirements, thereby increasing overall residual risk.",
    "警告考虑本身可以充分降低个人风险。然而，过多的警告可能会使用户感到困惑，从而降低单一警告的效果。可能需要进行分析以确定是否过度依赖警告以及这种过度依赖是否会对风险降低和整体剩余风险产生影响。": "Warnings alone may sufficiently reduce individual risk. However, excessive warnings may confuse the user, reducing the effectiveness of a single warning. Analysis may be needed to determine if there is over-reliance on warnings and if such over-reliance impacts risk reduction and overall residual risk.",
    "对医疗器材的所有操作说明进行全面审查可能会发现这些说明不一致或太难遵循。": "A comprehensive review of all operating instructions for the medical device may reveal inconsistencies or difficulty in following them.",
    "设计验证、可用性研究、临床评估、临床前评估和临床调查的结果可以提供有关整体残留风险的有用信息。": "Results from design verification, usability studies, clinical evaluation, pre-clinical evaluation and clinical investigations can provide useful information regarding overall residual risk.",
    "应考虑个别风险的所有效益": "All benefit-risk analysis of individual risks should be considered.",
    "当": "When ",
    "中存在风险之间的权衡时，应格外谨慎地分析对整体剩余风险的影响。": "there are trade-offs between risks, the impact on overall residual risk should be analyzed with extra caution.",
    "评估总体残余风险的方法可以采取以下途径：": "Methods for evaluating overall residual risk may include:",
    "与医疗器材": "With the medical device ",
    "相关的益处与整体残余风险进行权衡。该评估将考虑适应症的知识、技术和医学领域公认的最新技术水平以及替代医疗设备或治疗的可用性。": "benefits weighed against overall residual risk. This evaluation will consider knowledge of the indications, state of the art in technology and medicine, and availability of alternative devices or treatments.",
    "残余风险的视觉表示可能很有用。每个单独的残余风险将显示在下列风险矩阵中。如果许多风险位于风险矩阵的较高": "Visual representation of residual risk may be useful. Each individual residual risk will be shown in the risk matrix below. If many risks are in the higher ",
    "性区域或较高机率区域，则风险的分布可能表明": "severity or probability regions, the distribution may indicate that the ",
    "可能不可接受，即使每个单独的风险已被判断为可接受。": "may be unacceptable, even if each individual risk has been judged acceptable.",
    "我们的医疗器械与市场上其他同类医疗器械的比较。考虑到": "Comparison of our device with other similar devices on the market. Considering ",
    "的差异，医疗器材造成的残余风险可以与类似医疗器材的相应风险进行单独比较。": "differences, the residual risk caused by the device can be compared individually with corresponding risks of similar devices.",
    "专家支持评估与使用所考虑的医疗器材的预期益处相关的整体残留风险。": "Expert support evaluates the overall residual risk relative to the expected benefits of using the device under consideration.",
    "尽管此时所有个别风险应已被识别、控制并判断为可接受，但作为整体剩余风险评估的结果，进一步调查某些风险可能是适当的。尤其是那些几乎不可": "Although all individual risks should have been identified, controlled and judged acceptable at this point, further investigation of certain risks may be appropriate as a result of overall residual risk evaluation. Especially those that are barely ",
    "接受的风险。": "acceptable risks.",
    "当某些风险与其原因或所采用的风险控制措施相互依赖时，进一步调查也是适当的。风险控制的有效性不仅要单独进行，还要与其他风险控制措施结合进行验证。失效分析(FMEA)和事件树分析(ETA)可以成为发现风险和风险控制措施之间关系的有用工具。": "Further investigation is also appropriate when certain risks are interdependent with their causes or risk control measures employed. The effectiveness of risk control must be verified not only individually but also in combination with other measures. FMEA and ETA can be useful tools to discover relationships between risks and controls.",
    "所有能够降低风险的风险控制措施应经过验证。验证将在风险管理报告中进行总结。风险控制措施的验证可以作为设计/开发验证和流程验证的一部分进行。然而，风险控制措施有效性的验证可以作为设计/开发验证的一部分进行。": "All risk control measures capable of reducing risk shall be verified. Verification will be summarized in the Risk Management Report. Verification of risk control measures can be performed as part of design/development verification and process validation. However, verification of effectiveness can be done as part of design/development verification.",
    "生产后信息将依照产品质量调查）、医疗器材报告、上市后信息收集监测（PMS））、上市后临床追踪（PMCF）符合ISO13485:2016Sec8.2“监测和测量”。": "Post-production information will follow product quality investigations, medical device reporting, Post-Market Surveillance (PMS), Post-Market Clinical Follow-up (PMCF) in compliance with ISO 13485:2016 Sec 8.2 'Monitoring and Measurement'.",
    "在风险管理过程中，我们利用临床前数据结果来识别器械相关危害并验证风险控制措施的有效性，然后透过不断收集、分析和评估临床数据，包括系统性临床评估中的临床效益来验证安全性设备的性能和性能，作为风险管理报告输入的一部分。": "In the risk management process, we use pre-clinical data results to identify device-related hazards and verify the effectiveness of risk control measures, then continuously collect, analyze and evaluate clinical data, including clinical benefits in systematic clinical evaluations, to verify safety and performance as part of Risk Management Report inputs.",
    "上市后风险管理活动": "Post-Market Risk Management Activities",
    "是否引入新危害;2.风险估计是否可接受;3.控制措施有效性验证": "1. New hazards introduced?; 2. Risk estimation acceptable?; 3. Control measure effectiveness verified?",
    "变更记录、风险文档更新": "Change Records, Risk Doc Update",
    "变更实施前": "Before Change",
    "等相关标准动态": "and other relevant standards updates",
    "法规符合性评价报告": "Regulatory Compliance Evaluation Report",
    "标准实施前": "Before Standard Implementation",
    "顾客投诉、不良事件、使用错误案例": "Customer Complaints, Adverse Events, Use Error Cases",
    "年度使用信息分析报告": "Annual Usage Info Analysis Report",
    "关键过程参数": "Key Process Parameters",
    "更新": "Update",
    "过程异常处理报告": "Process Anomaly Handling Report",
    "异常发生后72小时": "72h after anomaly",
    "处理": "Handling",
    "现象描述": "Phenomenon Description",
    "请更换新": "Please replace with new",
    "肾上腺素急救笔": "Epinephrine Auto-Injector",
    "未完全止退": "Incomplete Retraction",
    "轻拉": "Gently pull",
    "推动": "Push",
    "完成止退": "Complete retraction",
    "注射后针尖有少量药液渗出": "A small amount of medication leakage from needle tip after injection",
    "是正常现象": "is normal",
    "不需要特殊处理": "no special handling required",
    "此": "This ",
    "不影响药剂": "does not affect the medication",
    "珍珠棉": "EPE Foam",
    "高分子": "Polymer",
    "生产Enterprise": "Production Enterprise",
    "生产住所": "Manufacturing Address",
    "以及": "and",
    "盲人": "Blind",
    "视力障碍": "Visually Impaired",
    "病人": "Patients",
    "必须在受过专门培训人员": "must be under the help of specially trained personnel",
    "浙江森迈合创医疗科技有限公司": "Zhejiang Summed Medtech Co., Ltd.",
    "轴向位置": "axial position",
    "图1": "Figure 1",
    "存在感染": "with infection",

    "帮助下": "help of",
    "使用本产品": "use this product",
    "禁止静脉内注射": "Intravenous injection is prohibited",
    "本品专为": "This product is designed for",
    "设计": "Design",
    "未经授权严禁复制": "Unauthorized reproduction is strictly prohibited",
    "空运、陆运、海运": "Air, Land, Sea Transport",
    "纸箱": "Carton",
    "角色": "Role",
    "主要职责": "Main Responsibilities",
    "人员/岗位资质与": "Personnel/Position Qualifications and",
    "测试设计员": "Test Designer",
    "设计测试方案": "Design Test Plan",
    "准备测试数据": "Prepare Test Data",
    "搭建测试环境": "Setup Test Environment",
    "熟悉业务需求和系统架构": "Familiar with business requirements and system architecture",
    "精通": "Proficient in",
    "测试执行员": "Test Executor",
    "执行测试": "Execute Test",
    "记录测试结果": "Record Test Results",
    "提交": "Submit",
    "具备执行": "Possess ability to execute",
    "所需": "Required",
    "基本技能": "Basic Skills",
    "清单": "List",
    "法规遵循原则以现行版为主": "Regulatory compliance principle is based on the current version",
    "如有变化，双方沟通": "If there are changes, both parties communicate",
    "学历:硕士": "Education: Master",
    "专业:生物医学工程": "Major: Biomedical Engineering",
    "工作经验": "Work Experience",
    "二类三类医疗器械研发工作经验": "Class II/III medical device R&D experience",
    "负责产品开发": "Responsible for product development",
    "技术Document制作": "Technical Document Preparation",
    "灭菌确认": "Sterilization Validation",
    "管理科学与": "Management Science and",
    "质量管理工作经验": "Quality Management experience",
    "熟悉质量管理体系运行": "Familiar with QMS operation",
    "内审员": "Internal Auditor",
    "材料工程": "Material Engineering",
    "生产、工艺经验": "Production/Process Experience",
    "负责过二类和三类研发、工艺和生产工作": "Responsible for Class II/III R&D, process and production",
    "全生命周期流程": "Full Lifecycle Process",
    "临床营养学系": "Clinical Nutrition",
    "化学品药剂、试剂与溶剂等供应商": "Chemical/Reagent/Solvent Suppliers",
    "专业针剂制药业": "Professional Injection Pharmaceutical Industry",
    "原料药到制剂生产": "API to Formulation Production",
    "生物药CDMO如单抗、疫苗、ADC": "Biologic CDMO such as Monoclonal Antibody, Vaccine, ADC",
    "给药装置": "Drug Delivery Device",
    "等稽核经验": "Audit Experience etc.",
    "生物化学与分子生物学": "Biochemistry and Molecular Biology",
    "药品研发": "Drug R&D",
    "药械组合产品法规注册": "Combination Product Regulatory Registration",
    "医疗器械临床质量管理规范": "Medical Device GCP",
    "强度、耐热性和": "Strength, Heat Resistance and",
    "韧性": "Toughness",
    "广泛应用": "Widely Used",
    "细胞毒性、致敏性和刺激性测试": "Cytotoxicity, Sensitization and Irritation Tests",
    "结果符合": "Results Comply with",
    "由于肾上腺素具有强效": "Since Epinephrine has potent",
    "升压作用": "pressor effect",
    "高血压危象": "Hypertensive Crisis",
    "未控制": "Uncontrolled",
    "症状性心律失常患者": "Symptomatic Arrhythmia Patients",
    "器质性脑损伤患者": "Organic Brain Damage Patients",
    "通常禁止使用": "Usually Contraindicated",
    "目录": "Table of Contents",
    "目标市场": "Target Market",
    "在医生指导": "Under Doctor's Guidance",
    "相对": "Relative",
    "无法": "Cannot",
    "触及": "reach",
    "及时": "timely",
    "编号": "No.",
    "要求": "Requirement",
    "必需/期望": "Required/Desired",
    "为一次性产品(PFS不可取出),固定剂量,自动注射,不需要调节剂量": "is a disposable product (PFS non-removable), fixed dose, auto-injection, no dose adjustment needed",
    "注射方式": "Injection Method",
    "肌肉注射": "Intramuscular Injection",
    "提供Cap保护": "provides Cap protection",
    "易于手拿": "Easy to hold",
    "符合人因工程外形Directions": "Conforms to ergonomic shape Dimensions",
    "为保证使用 of 方便性": "To ensure ease of use",
    "Cap拉拔力应": "Cap pull force shall be",
    "并": "and",
    "激发Needle Cap开始注射 of 按压力应": "Actuation force to trigger Needle Cap for injection shall be",
    "具有注射后针头保护盖自锁功能": "Has post-injection needle shield self-lock function",
    "应通过视觉、听觉、触觉or以上方式 of 组合": "Shall indicate injection completion via visual, auditory, tactile or combination",
    "显示注射已完成": "indicate injection completion",
    "正常运输 and 储存条件下": "Under normal transport and storage conditions",
    "产品功能不受影响": "product function is not affected",
    "保质期": "Shelf Life",
    "年": " years",
    "缩写 and 术语": "Abbreviations and Terms",
    "缩略词": "Abbreviation",
    "英文Definition": "English Definition",
    "中文Definition": "Chinese Definition",
    "国际Standard化组织": "International Organization for Standardization",
    "美国Material实验协会": "American Society for Testing and Materials",
    "职能Department": "Functional Department",
    "企业负责人": "Enterprise Head",
    "生产管理负责人": "Production Management Head",
    "质量管理负责人": "Quality Management Head",
    "研发负责人": "R&D Head",
    "负责人": "Person in Charge",
    "联系电话": "Contact Number",
    "防水等级": "Waterproof Rating",
    "使用环境": "Usage Environment",
    "环境温度": "Ambient Temperature",
    "相对湿度": "Relative Humidity",
    "大气压力": "Atmospheric Pressure",
    "注射理论剂量": "Theoretical Injection Dose",
    "注射剂量Scope": "Injection Dose Range",
    "注射时间": "Injection Time",
    "不含停留时间": "excluding dwell time",
    "注射按压力": "Injection Actuation Force",
    "自动注射器存放在儿童不能触及的地方": "Store Auto-Injector out of reach of children.",
    "应存放在阴凉、干燥处": "should be stored in a cool, dry place",
    "未装药物情况下": "without drug loaded",
    "并在相同条件下运输": "and transported under the same conditions",
    "若以下处理方式仍无法解决您的问题": "If the following methods cannot solve your problem",
    "请及时联系经销商or生产商": "please contact the dealer or manufacturer in time",
    "咨询解决": "for consultation/solution",
    "药品 and 内包材信息": "Drug and Primary Packaging Information",
    "具备执行测试用例所需 of 基本技能": "Possess basic skills required to execute test cases",
    "警告（确保正确应用）": "Warning (Ensure Correct Application)",
    "设计失效模式和后果分析": "Design Failure Mode and Effects Analysis",
    "历史": "History",
    "试验时间表": "Test Schedule",
    "放样Date": "Sample Placement Date",
    "总放样量": "Total Placed Qty",
    "取样Date": "Sampling Date",
    "放样量/支": "Placed Qty (pcs)",
    "取样量/支": "Sampled Qty (pcs)",
    "符合人因工程外形Dimensions": "Conforms to ergonomic shape Dimensions",
    "人因工程": "ergonomics",
    "外形": "shape",
    "方便性": "convenience",
    "拉拔力": "pull force",
    "按压力": "actuation force",
    "自锁功能": "self-lock function",
    "视觉": "visual",
    "听觉": "auditory",
    "触觉": "tactile",
    "组合": "combination",
    "功能": "function",
    "不受影响": "not affected",
    "术语": "Terms",
    "国际标准化组织": "International Organization for Standardization",
    "美国材料实验协会": "American Society for Testing and Materials",
    "企业": "Enterprise",
    "管理": "Management",
    "联系": "Contact",
    "电话": "Telephone",
    "防水": "Waterproof",
    "等级": "Rating",
    "环境": "Environment",
    "温度": "Temperature",
    "理论": "Theoretical",
    "剂量": "Dose",
    "时间": "Time",
    "停留": "Dwell",
    "存放": "Store",
    "儿童": "Children",
    "不能": "Cannot",
    "地方": "Place",
    "阴凉": "Cool",
    "干燥": "Dry",
    "处": "Place",
    "药物": "Drug",
    "情况": "Condition",

    "相同": "Same",
    "条件": "Condition",
    "以下": "Following",
    "处理方式": "Handling Method",
    "仍": "Still",
    "解决": "Solve",
    "问题": "Problem",
    "经销商": "Dealer",
    "内包材": "Primary Packaging",
    "具备": "Possess",
    "执行": "Execute",
    "测试用例": "Test Case",
    "所需": "Required",
    "基本": "Basic",
    "技能": "Skill",
    "警告": "Warning",
    "确保": "Ensure",
    "正确": "Correct",
    "应用": "Application",
    "失效模式": "Failure Mode",
    "后果": "Effects",
    "分析": "Analysis",
    "放样": "Placement",
    "取样": "Sampling",
    "总量": "Total Qty",
    "支": "pcs",
    "责任部门": "Responsible Dept.",
    "完成时限": "Timeline",
    "以及": "and",

    "进行": "conduct",
    "汇总和分析": "summary and analysis",
    "根据": "according to",
    "预进入的目标市场": "target market intended to enter",
    "视情况": "as appropriate",
    "依据": "based on",
    "或": "or",
    "生物相容性评价进行规划": "biological compatibility evaluation planning",
    "以确保产品的安全性和有效性": "to ensure the safety and effectiveness of the product",
    "范围": "Scope",
    "本Document适用于欣捷达Auto-Injector的生物相容性评价": "This document applies to the biological compatibility evaluation of the Simject Auto-Injector.",
    "产品描述": "Product Description",
    "及": " and ",
    "适用于搭配肾上腺素(预充式0.3mL)进行药液传输(肌肉、注射)仅供单个患者或个人使用": "Intended for use with Epinephrine (Pre-filled 0.3mL) for drug delivery (intramuscular injection). For single patient or personal use only.",
    "用于抢救紧急过敏反应(如过敏性休克，哮喘)、心脏骤停等Patients（未成年人和成年人）。注射部位存在感染、炎症或皮肤破损者禁用": "Used for rescue of emergency allergic reactions (e.g., anaphylactic shock, asthma), cardiac arrest, etc. Patients (minors and adults). Contraindicated for injection sites with infection, inflammation, or broken skin.",
    "产品组成结构": "Product Composition/Structure",
    "欣捷达Auto-Injector由前组件、后组件及笔帽组件组成，其中后组件的注射助推器由注射器载体和动力弹簧装置两部分组成": "The Simject Auto-Injector consists of a Front Assembly, Rear Assembly, and Cap Assembly. The injector booster of the Rear Assembly consists of a Syringe Carrier and a Power Spring Unit.",
    "包装信息": "Packaging Information",
    "欣捷达Auto-Injector包装包括支撑托盘、纸盒、外包装箱": "The Simject Auto-Injector packaging includes support trays, paper boxes, and outer shipping cartons.",
    "灭菌信息": "Sterilization Information",
    "欣捷达Auto-Injector为非无菌提供，不涉及灭菌活动": "The Simject Auto-Injector is supplied non-sterile and does not involve sterilization activities.",
    "货架寿命和运输储存对生物相容性影响的评价": "Evaluation of Shelf Life and Transport/Storage Impact on Biocompatibility",
    "欣捷达Auto-Injector运输储存条件": "Simject Auto-Injector Transport and Storage Conditions:",
    "储存条件：温度": "Storage Conditions: Temperature",
    "湿度": "Humidity",
    "运输方式：空运或陆运": "Transport Mode: Air or Land",
    "欣捷达Auto-Injector生物相容性不会受到货架寿命的影响": "The biocompatibility of the Simject Auto-Injector will not be affected by shelf life.",
    "理由：欣捷达Auto-Injector产品使用的高分子材料PC+ABS、PC等材料在正常使用条件下不易降解。基于其物理特性，欣捷达Auto-Injector中高分子材料的生物相容性不会受到货架寿命的影响": "Reason: The polymer materials PC+ABS, PC, etc., used in the Simject Auto-Injector are not easily degraded under normal use conditions. Based on their physical properties, the biocompatibility of the polymer materials in the Simject Auto-Injector will not be affected by shelf life.",
    "生产信息": "Production Information",
    "生产地址": "Manufacture Address",
    "欣捷达Auto-Injector半成品和成品均在嘉兴森迈医疗科技有限公司生产车间内生产，生产地址：浙江省嘉兴市嘉善县罗星街道灵秀路313号8幢5层": "Both semi-finished and finished Simject Auto-Injectors are produced in the production workshop of Jiaxing Summed Medtech Co., Ltd. Address: 5th Floor, Building 8, No. 313 Lingxiu Road, Luoxing Sub-district, Jiashan County, Jiaxing City, Zhejiang Province.",
    "制造过程": "Manufacturing Process",
    "材料和化学表征": "Material and Chemical Characterization",
    "与病人直接接触或间接接触的材料": "Materials in Direct or Indirect Contact with Patients",
    "名称": "Name",
    "材料": "Material",
    "与人体接触类型": "Contact Type",
    "接触皮肤时间": "Skin Contact Duration",
    "垫环": "Washer",
    "热塑性弹性体(TPE)": "Thermoplastic Elastomer (TPE)",
    "不接触": "Non-contact",
    "针筒套筒": "Syringe Sleeve",
    "聚碳酸酯(PC)": "Polycarbonate (PC)",
    "针盖": "Needle Cap",
    "聚碳酸酯-丙烯腈of聚物(PC+ABS)": "Polycarbonate-Acrylonitrile Copolymer (PC+ABS)",
    "直接接触": "Direct Contact",
    "笔杆": "Pen Barrel",
    "延长笔杆": "Extension Barrel",
    "笔帽": "Cap",
    "铁扣": "Iron Clip",
    "304不锈钢(SUS304)": "304 Stainless Steel (SUS304)",
    "后盖": "Rear Cap",
    "执行套杆": "Actuator Sleeve",
    "聚甲醛(POM)": "Polyoxymethylene (POM)",
    "套筒": "Sleeve",
    "推杆": "Plunger",
    "推杆弹簧": "Plunger Spring",
    "针盖弹簧": "Needle Cover Spring",
    "加工助剂、过程残留物和其他有可能残留在器械上的添加剂": "Processing Aids, Process Residues, and Other Additives Potentially Remaining on the Device",
    "无": "None",
    "材料的安全性研究": "Material Safety Study",
    "是一种高性能的热塑性塑料，具有优异的物理和化学特性，广泛应用于工业、电子、医疗、建筑等领域，高强度抗冲击性强，长期使用温度可达": "is a high-performance thermoplastic with excellent physical and chemical properties, widely used in industrial, electronics, medical, construction, and other fields. High strength and impact resistance, long-term use temperature up to ",
    "短期可耐": "Short-term resistance ",
    "以上，但易被有机溶剂（如丙酮、强碱）腐蚀。长期暴露在紫外线下会变黄。其细胞毒性、致敏性和刺激性测试（如MTT法、皮内反应试验）结果符合ISO10993-5、-10、-23的要求。通常生物相容性良好，但需关注残留单体双酚A（BPA）及可能水解降解的风险": "or above, but easily corroded by organic solvents (e.g., acetone, strong alkalis). Long-term exposure to UV light causes yellowing. Its cytotoxicity, sensitization, and irritation test results (e.g., MTT method, intracutaneous reactivity test) meet the requirements of ISO 10993-5, -10, -23. Usually has good biocompatibility, but attention should be paid to the risk of residual monomer Bisphenol A (BPA) and potential hydrolytic degradation.",
    "详见AppendixA《PC Material Review Report》": "See Appendix A 'PC Material Review Report'",
    "详见AppendixB《PC+ABS Material Review Report》": "See Appendix B 'PC+ABS Material Review Report'",
    "详见附件1：产品外观效果图": "See Attachment 1: Product Appearance Rendering",
    "说明 Note: 目视及手测必须经过培训, 确保质量的一致性。量测请避开进浇点。": "Note: Visual and manual inspection must be trained to ensure consistency of quality. Avoid injection gates when measuring.",
    "请保持产品干燥，勿让水或其它液体进入产品内部。": "Keep the product dry. Do not allow water or other liquids to enter the product.",
    "请勿使用烈性化学制品、洗涤剂或强洗涤剂清洁注射助推器及其配件。": "Do not use harsh chemicals, detergents, or strong cleaners to clean the injector booster and its accessories.",
    "请勿使自动注射器及其配件受到强烈的冲击或震动，以免损坏外壳及其内部组件。": "Do not subject the auto-injector and its accessories to strong impact or vibration to avoid damaging the housing and internal components.",
    "请勿对注射助推器及其配件进行蒸汽消毒或者高压消毒。": "Do not steam sterilize or autoclave the injector booster and its accessories.",
    "请勿将本产品浸入水中，否则会导致产品损坏。": "Do not immerse this product in water, otherwise it will cause product damage.",
    "请勿擅自拆卸注射助推器及其内部组件，否则该设备将不在本公司保修的范围之内。": "Do not disassemble the injector booster and its internal components without authorization, otherwise the device will not be covered by our warranty.",
    "请小心存放本产品。防止水、灰尘和潮气进入。": "Store this product carefully. Prevent water, dust, and moisture from entering.",
    "请按照《100-005-TIS-023 V1.0总装》进行三个独立批次，每个批次样品10支进行功能测试。": "Please perform functional testing on three independent batches, 10 samples per batch, according to '100-005-TIS-023 V1.0 General Assembly'.",
    "请遵循本产品的使用说明，并且要在和您的医生和/或专业医护人员交流后才能使用本产品。": "Follow the instructions for use of this product and use only after consulting with your doctor and/or healthcare professional.",
    "运输单元：将经受流通环境的最小完整单元，例如运输容器及其内容物。": "Transport Unit: The smallest complete unit that will withstand the distribution environment, e.g., the shipping container and its contents.",
    "运输和存放应避免阳光直射，勿靠近热源，请勿冷冻。": "Avoid direct sunlight during transport and storage, keep away from heat sources, do not freeze.",
    "适用于搭配肾上腺素（预充式": "Intended for use with Epinephrine (Pre-filled ",
    "适用于新博研桥专案产品加速老化评价，包括加速老化和产品性能验证。": "Applies to accelerated aging evaluation of the Simject project product, including accelerated aging and product performance verification.",
    "适用于新博研桥专案产品实时老化评价，包括实时老化和产品性能验证。": "Applies to real-time aging evaluation of the Simject project product, including real-time aging and product performance verification.",
    "适用患者": "Applicable Patients",
    "适用范围（Intended Use）：": "Intended Use:",
    "通过视窗检查药剂外观，若药剂发生变性请勿使用。": "Check the appearance of the medicament through the window. Do not use if the medicament has deteriorated.",
    "遵循医生和/或专业医护人员的指导，在合适的部位进行注射。": "Follow the guidance of a doctor and/or healthcare professional to inject at the appropriate site.",
    "避免产品跌落或接触硬物。请勿将产品浸入水中或任何液体中。": "Avoid dropping the product or contacting hard objects. Do not immerse the product in water or any liquid.",
    "避免将产品放置到极端的温度环境下，包括高温、低温、阳光直射等条件下。": "Avoid placing the product in extreme temperature environments, including high heat, low temperature, direct sunlight, etc.",
    "避免阳光直射或骤冷骤热的条件下存放和运输。": "Avoid storage and transport under direct sunlight or sudden temperature changes.",
    "部件制造商型号规格预灌封注射器组合件(带注射针)参考附件31ml(长)22G长度:84.5±1.0mm针管外直径:8.15±0.1mm针管内直径:6.35±0.1mm法兰直径:13.8±0.4mm法兰厚度:1.65±0.25mm硅油量:≤0.7mg/支胶塞参考附件41ml(长)C2574胶塞在带针预灌封(PFS)中的轴向位置A或B(见下图1)供货时提供B测试数据其他如需请补充": "Component Manufacturer Model Spec PFS Assembly (w/ Needle) Ref Attachment 3 1ml(Long) 22G Length: 84.5±1.0mm Outer Dia: 8.15±0.1mm Inner Dia: 6.35±0.1mm Flange Dia: 13.8±0.4mm Flange Thick: 1.65±0.25mm Silicon Quantity: <=0.7mg/pc Plunger Ref Attachment 4 1ml(Long) C2574 Plunger Axial Position A or B in PFS (See Fig 1 below) B test data provided at delivery. Supplement if others needed.",
    "部件类别": "Component Category",
    "风险物质": "Risk Substances",
    "PC 部件": "PC Components",
    "双酚 A (BPA) 残留等": "Bisphenol A (BPA) Residues etc.",
    "PC+ABS 部件": "PC+ABS Components",
    "双酚 A (BPA)、丙烯腈单体等": "Bisphenol A (BPA), Acrylonitrile Monomer etc.",
    "采用DC-4+DC6原则": "Adopt DC-4 + DC6 Principle",
    "附件. 6": "Attachment 6",
    "附件1：产品外观效果图": "Attachment 1: Product Appearance",
    "附件3：预灌封注射器组合件（带注射针）": "Attachment 3: Pre-filled Syringe Assembly (with Needle)",
    "附件4：胶塞": "Attachment 4: Plunger Stopper",
    "零部件名称": "Component Name",
    "零部名称": "Part Name",
    "需要肌肉注射药物Patients（未成年人和成年人）。用户应视力和听力正常，能阅读、理解说明书，经培训后能正确使用产品。成人在医生指导下使用本产品，未经培训，请勿使用。未成年人应在监护人、医生的帮助下使用，切勿自行使用。": "Patients requiring intramuscular injection (minors and adults). Users should have normal vision and hearing, be able to read and understand usage instructions, and correctly use the product after training. Adults should use this product under doctor's guidance; do not use without training. Minors should use under the help of guardians or doctors; do not use independently.",
    "项目": "Item",
    "项目/专案名称": "Project Name",
    "新博研桥": "Simject",
    "专案": " Project",
    "项目/专案代码": "Project Code",
    "项目/专案经理": "Project Manager",
    "研发工程师": "R&D Engineer",
    "生效": "Effective ",
    "审批记录": "Approval Record",
    "起草人": "Drafter",
    "规格标准及说明": "Specifications and Descriptions",
    "尺寸参考规格图": "Size Reference Specification Drawing",
    "检验方法/设备": "Test Methods/Equipment",
    "标准": "Standard",
    "方法": "Test Method",
    "设备编号": "Equipment No.",
    "允收標準": "Acceptance Criteria",
    "抽样计划水平": "Sampling Plan Level",
    "尺寸": "Dimensions",
    "前端面至卡扣长度": "Length from front face to snap",
    "游标卡尺": "Vernier Caliper",
    "或相同规格设备": "or equivalent equipment",
    "外径": "Outer Diameter",
    "总长": "Total Length",
    "外观": "Appearance",
    "产品上不可有划伤、裂痕、色泽不一致、毛刺等缺陷。": "Product must be free of scratches, cracks, inconsistent color, burrs, and other defects.",
    "目视": "Visual",
    "参考图纸": "Reference Drawing",
    "卡扣长度": "Snap Length",
    "后盖面长度": "Rear Cap Face Length",
    "后盖面宽度": "Rear Cap Face Width",
    "颜色:灰色": "Color: Gray",
    "发行章": "Issue Stamp",
    "项目代码": "Project Code",
    "项目名称": "Project Name",
    "项目编号": "Project Number",
    "项目要求名称": "Project Requirement Name",
    "肾上腺素注射液(预充式)药品信息": "Epinephrine Injection (Pre-filled) Drug Information",
    "本品为无色或几乎无色的澄明液体,受日光照射或空气接触易变质,于遮光、密闭、20~25℃保存": "This product is a colorless or almost colorless clear liquid, easily deteriorated by sunlight or air contact. Store in dark, sealed, 20-25 deg C.",
    "治疗领域": "Therapeutic Area",
    "用于抢救紧急过敏反应(过敏性休克、哮喘)、心脏骤停等": "For rescue of anaphylaxis (shock, asthma), cardiac arrest, etc.",
    "规格剂量": "Spec/Dose",
    "成人款": "Adult Version",
    "儿童款": "Pediatric Version",
    "灌装": "Fill",
    "一次性注射": "Single Injection",
    "保留两位小数点": "Keep 2 decimal places",
    "针头伸出长度": "Needle Extension Length",
    "动力粘度": "Dynamic Viscosity",
    "同步检测注射用水,粘度伟1.04cP": "Synchronous test WFI, viscosity is 1.04cP",
    "检测条件:液体温度": "Test Condition: Liquid Temp",
    "密度": "Density",
    "其他补充": "Other Supplements",
    "根据用户的《注射剂量标准通知函》进行相应调整,详见附件2。": "Adjust according to user's 'Injection Dose Standard Notification'; see Attachment 2.",
    "验收标准": "Acceptance Criteria",
    "运输单元经受测试计划后必须达到的可接受质量水平。": "Acceptable quality level that the transport unit must achieve after subjecting to the test plan.",
    "验证simject系列-新博研桥（成人）专案产品在自由坠落试验，仍能保持其性能符合要求。": "Verify that Simject series (Adult) project products maintain performance requirements after free fall test.",
    "验证新博研桥专案产品在规定的储存条件下，在有效期内保持其性能符合预期要求。": "Verify that Simject project products maintain expected performance requirements within shelf life under prescribed storage conditions.",
    "验证新博研桥（成人）专案产品在经过模拟运输试验，仍能保持其性能符合要求。": "Verify that Simject (Adult) project products maintain performance requirements after simulation transport test.",
    "验证新博研桥（成人）专案产品性能符合要求。": "Verify that Simject (Adult) project product performance meets requirements.",
    "（一）": "(1) ",
    "（七）禁忌症、注意事项、警示以及提示的内容": "(7) Contraindications, Precautions, Warnings, and Tips",
    "（三）": "(3) ",
    "（九）产品维护和保养方法，特殊储存、运输条件、方法：": "(9) Product Maintenance, Special Storage/Transport Conditions/Methods:",
    "（二）": "(2) ",
    "（五）产品技术要求的编号：": "(5) Product Technical Requirement No.: ",
    "（八）安装和使用说明": "(8) Installation and Usage Instructions",
    "（六）产品性能、主要结构组成、适用范围": "(6) Product Performance, Main Structure, Scope of Application",
    "（十一）常见问题及处理方式": "(11) FAQ and Handling",
    "（十三）图形、符号、缩写说明": "(13) Graphics, Symbols, Abbreviations",
    "（十二）技术信息": "(12) Technical Information",
    "（十四）说明书": "(14) Instructions for Use ",
    "（十）产品使用期限": "(10) Product Shelf Life",
    "（四）医疗器械注册证编号：": "(4) Medical Device Registration Certificate No.: ",
    "试验顺序": "Test Sequence",
    "试验计划": "Test Plan",
    "备注": "Remark",
    "环境预处理": "Env Pre-conditioning",
    "23±1℃, 50±2%RH 处理时间:72 小时": "23+/-1C, 50+/-2%RH, Time: 72h",
    "计划A人工搬运初始跌落测试": "Plan A Manual Handling Initial Drop Test",
    "计划C车载堆码压缩测试": "Plan C Vehicle Stacking Compression Test",
    "计划D堆码振动振动测试": "Plan D Stacked Vibration Test",
    "计划E车载振动振动测试": "Plan E Vehicle Vibration Test",
    "计划F无约束振动重复性冲击": "Plan F Loose Cargo Vibration Repetitive Shock",
    "计划H环境危害": "Plan H Environmental Hazard",
    "不适用": "N/A",
    "计划J集中冲击": "Plan J Concentrated Impact",
    "计划A人工搬运最终跌落测试": "Plan A Manual Handling Final Drop Test",
    "计划B仓库堆叠": "Plan B Warehouse Stacking",
    "以及": "and",
    "学历": "Education",
    "硕士": "Master",
    "博士": "PhD",
    "专业": "Major",
    "从事": "Engaged in",
    "近": "Nearly ",
    "以上": " or more",
    "完好无损": "intact and undamaged",
    "无损": "undamaged",
    "欣捷达Auto-Injector运输储存Condition": "Simject Auto-Injector Transport and Storage Conditions",
    "是精密医疗设备，请避免": "is a precision medical device, please avoid",
    "高温、极低温、潮湿、灰尘等恶劣Environment": "high temperature, extremely low temperature, humidity, dust and other harsh environments",
    "应避免跌落，强烈撞击，以免损坏设备": "avoid dropping, strong impact, to avoid damaging the device",
    "同欣捷达": "Same as Simject",
    "每次注射前，请确认您 of 注射笔中 of PFS胶塞位置": "Before each injection, please check the PFS plunger stopper position in your injector",
    "确认笔芯": "confirm cartridge",
    "且与厂家提供 of": "and consistent with the manufacturer provided",
    "相符": "consistent",
    "注册人Name": "Registrant Name",
    "注册人住所": "Registrant Residence",
    "注射完成以后，请按照When 地医疗器械废弃物Handling规范conductHandling": "After injection is complete, please handle according to local medical device waste handling regulations",
    "注射完成后，请按照When 地医疗器械废弃物Handling规范conductHandling": "After injection is complete, please handle according to local medical device waste handling regulations",
    "注射流程图": "Injection Flowchart",
    "流程、工具使用和缺陷判定": "Process, Tool Usage and Defect Determination",
    "流通周期": "Distribution Cycle",
    "按顺序列出 of 测试计划": "Test plan listed in sequence",
    "用于模拟运输单元从生产到消费 of 特定路径中预期遇到 of 危害要素": "intended to simulate hazard elements expected to be encountered in the specific path of the transport unit from production to consumption",
    "测试参数": "Test Parameters",
    "模拟": "Simulate",
    "测试实验室 of": "Test Laboratory",
    "必须控制": "must be controlled",
    "以本文档为基础": "Based on this document",
    "按本文档 of": "According to this document's",
    "来Execute产品 of": "to execute product",
    "聚碳酸酯-丙烯腈-丁二烯-苯乙烯of聚物": "Polycarbonate-Acrylonitrile-Butadiene-Styrene Copolymer",
    "(预充式)": "(Pre-filled)",
    "预充式": "Pre-filled",
    "应当": "Shall",
    "当地": "Local",
    "当地医疗器械废弃物处理规范": "local medical device waste handling regulations",
    "嘉兴森迈医疗科技有限公司生产车间内生产": "produced in the production workshop of Jiaxing Summed Medtech Co., Ltd.",
    "Cap组件": "Cap Assembly",
    "在正常使用条件下": "under normal use conditions",
    "同欣捷达": "Same as Simject",
    "PFS胶塞位置": "PFS plunger stopper position",
    "GCP培训": "GCP Training",
    "培训": "Training",
    "技术文档制作": "Technical Document Preparation",
    "医疗器械废弃物处理": "medical device waste handling",
    "监护人、医生的帮助下": "the help of guardians or doctors",
    "在医生指导下使用本产品": "Use this product under doctor's guidance",
    "医生指导下": "under doctor's guidance",
    "未经培训": "without training",
    "切勿自行使用": "Do not use independently",
    "视力和听力正常": "normal vision and hearing",
    "能阅读、理解说明书": "can read and understand the instructions",
    "经培训后能正确使用产品": "can use the product correctly after training",
    "具备执行测试用例所需的基本技能": "Possess the basic skills required to execute test cases",
    "您": "your",
    "中的": " in the ",
    "请确认": "please confirm",
    "森迈": "Summed",
    "产品法规标准清单": "Product Regulatory Standard List",
    "所有与皮肤接触部件": "All skin contact parts",
    "化学表征": "Chemical Characterization",
    "皮肤致敏性": "Skin Sensitization",
    "皮肤刺激性": "Skin Irritation",
    "适用部件": "Applicable components",
    "评价项目": "Evaluation Item",
    "（同欣捷达）": "(Same as Simject)",
    "组件组成": "consists of components",
    "质量管理体系": "Quality Management System",
    "风险管理": "Risk Management",
    "的": " ",
    "of聚物": "Copolymer",
    "未成年": "Minors",
    "成年": "Adults",
    "支撑": "Support",
    "见下": "See below",
    "or皮肤": "or skin",
    "未成年人": "Minors",
    "成年人": "Adults",
    "of聚物": " Copolymer",
    "李洁": "Kayla Li",
    "罗亿良": "Kevin Lo",
    "薛媛媛": "Grace Xue",
    "张琪裴": "Doris Chang",
    "高张昀": "ZY Gao",
    "杨荣壬": "Zen Yang",
    "蔡大中": "Andy Tsai",
    "赵佃佳": "Logan Zhao",
    "周锐英": "Ryzer Zhou",
    "庞天雨": "Rain Pang",
    "熊芊芊": "Timi Xiong",
    "井天奇": "Lynn Jing",
    "何佩玲": "Linda He",
    "王倩倩": "Hanna Wang",
    "徐俊": "Jimmy Xu",
    "王艳玲": "Linda Wang",
    "郑阳春": "YC Zheng",
    "黎德辉": "Alex Li",
    "张福昌": "Alex Chong",
    "高鹏涛": "Alvin Gao",
    "洪宇良": "YL Hong",
    "蔡怡妮": "Yini Chai",
    "徐宽": "Kuan Xu",
    "张秋燕": "Iris Zhang",
    "黄贞桢": "ZZ Huang",
    "徐瑜欣": "Coco Xu",
    "翁晨俊": "Nic Weng",
    "翁臣俊": "Nic Weng",
    "卢阳": "Lu Yang", # Extra one seen in logs previously
    "万立祥": "Wan Lixiang", # Extra one seen in logs
    "曾伟宏": "Zeng Weihong", # Extra one seen in logs
    "林琴": "Lin Qin", # Extra one seen in logs
    "负责": "Responsible", # Common prefix with names
    "（": "(",
    "）": ")",
    "和": " and ",
    "欣捷达 (Simject)": "Simject",
    "Simject (Simject)": "Simject", # Handline potential double translate
    "应在": "should be under ",
    "Minors应在": "Minors should be under ",
    "使用": "use",
    "Minors应在the help of guardians or doctors使用": "Minors should be under the help of guardians or doctors to use", # Full sentence fix
    "Do not use independently": "Do not use independently", # Already there, just confirming
    "Minors人和Adults人": "Minors and Adults", # Fix the 'ren' char which means people/person
    "Minors人": "Minors",
    "Adults人": "Adults",
    "Minorsshould": "Minors should",
    "doctorsuse": "doctors to use",
    "(下Same as Simject)": "(Same as Simject)",
    "PolymerMaterial": "Polymer Material",
    "Materialunder": "Material under",
    "(Pre-filled)成人": "(Pre-filled) Adult",
    "Patients(Minors and Adults)": "Patients (Minors and Adults)",
    "欣捷达(Simject)部分": "Simject Section",
    "Product Descriptionconsistent": "Product Description consistent",
    "confirmyour": "confirm your",
    "please confirm": "Please confirm",
    "Minorsand": "Minors and",
    
    # Fixes for terms identified in User Screenshot
    "产品Design": "Product Design",
    "过程变更": "Process Change",
    "Standard法规": "Standard/Regulation",
    "规Update": "Regulation Update",
    "市场use信息": "Market Use Information",
    "生产工艺稳定性": "Production Process Stability",
    "PFMEAUpdate": "PFMEA Update",
    "工艺": "Process",
    "稳定性": "Stability",
    "Change": "Change",
    "信息": "Information",
    "预灌封注射器": "Pre-filled Syringe",
    "不涉": "does not involve",
    "灭菌": "sterilization",
    "托盘": "Tray",
    "Support托盘": "Support Tray",
    "Manufacture Address": "Manufacturing Address",
    "注射完成": "Injection Complete",
    "注射完成后": "After Injection Complete",
    "请按照": "Please follow",
    "测试实验室": "Testing Laboratory",
    "理由": "Justification",
    "基于其物理特性": "Based on its physical properties",
    "生物相容性": "Biocompatibility",
    "不会受到货架寿命 影响": "will not be affected by shelf life",
    "货架寿命": "Shelf Life",
    "生产Enterprise": "Manufacturing Enterprise",
    "生产": "Production",
    "注射部位": "Injection Site",
    "炎症": "inflammation",
    "皮肤破损": "broken skin",
    "者禁用": "prohibited for those",
    "用户需求": "User Requirement",
    "内部Document": "Internal Document",
    "严禁复制": "Unauthorized reproduction is strictly prohibited",
    "聚碳酸酯-丙烯腈-丁二烯-苯乙烯": "Polycarbonate-Acrylonitrile-Butadiene-Styrene",
    "结合了": "Combines",
    "于": " in ", # Contextual "in"
    "Widely Used于": "Widely Used in",
    "通常": "Usually",
    "但需关注": "but need to pay attention to",
    "残留单体": "residual monomers",
    "丙烯腈": "Acrylonitrile",
    "双酚A": "Bisphenol A",
    "可能影响结果": "may affect results",
    "风险": "Risk",
    "药品": "Drug",
    "见Summed提供": "See Summed provided",
    "提供": "provided",
    "参见": "Refer to",
    "附件": "Appendix",
    "参考": "Refer to",
    "供货时": "When supplied",
    "其他如需请补充": "Others please supplement if needed",
    "法兰直径": "Flange Diameter",
    "法兰厚度": "Flange Thickness",
    "硅油量": "Silicone Oil Quantity",
    "胶塞": "Rubber Stopper",
    "在带针": "In needle-staked",
    "供货时提供": "Provide when supplied",
    "测试数据": "Test Data",
    "需要": "Need",
    "用户应": "Users should have",
    "请勿": "Please do not",
    "成人": "Adults",
    "Simject部分": "Simject Section",
    "部分": "Section",
    "概率": "Probability",
    "为非": "is non-",
    "本方案": "This Plan",
    "本产品": "This Product",
    "本说明书": "This Manual",
    "本研究": "This Study",
    "本Document": "This Document",
    "适用 scope": "Applicable Scope",
    "适用": "Applies to",
    "项目": "Project",
    "系列": "Series",
    "设备": "Equipment",
    "示意图": "Diagram",
    "简述": "Description",
    "生产商": "Manufacturer",
    "批号": "Batch No.",
    "组件": "Component",
    "前组件": "Front Component",
    "后组件": "Rear Component",
    "总成": "Assembly",
    "工装": "Tooling",
    "夹具": "Fixture",
    "终端": "Final",
    "组装": "Assembly",
    "保护": "Protection",
    "锐器": "Sharps",
    "伤害": "Injury",
    "有限公司": "Co., Ltd.",
    "科技": "Technology",
    "医药": "Pharmaceutical",
    "福州": "Fuzhou",
    "嘉兴": "Jiaxing",
    "浙江省": "Zhejiang Province",
    "嘉善县": "Jiashan County",
    "街道": "Street",
    "号": "No.",
    "幢": "Building",
    "层": "Floor",
    "地址": "Address",
    "电话": "Tel",
    "传真": "Fax",
    "邮箱": "Email",
    "日期": "Date",
    "签名": "Signature",
    "审核": "Reviewed",
    "批准": "Approved",
    "编制": "Prepared",
    "或者": "or",
    "以及": "and",
    "包括": "including",
    "例如": "e.g.",
    "如": "such as",
    "等": "etc.",
    "无": "None",
    "非": "Non-",
    "均": "all",
    "位于": "located in",
    "进行": "conduct",
    "操作": "operate",
    "维护": "maintain",
    "保养": "care",
    "储存": "store",
    "环境": "environment",
    "温度": "temperature",
    "湿度": "humidity",
    "大气压": "atmospheric pressure",
    "范围": "range",
    "控制": "control",
    "标准": "Standard",
    "符合": "Comply with",
    "图": "Figure",
    "表": "Table",
    "样品": "Sample",
    "数量": "Quantity",
    "结果": "Result",
    "合格": "Pass",
    "不合格": "Fail",
    "备注": "Remark",
    "名称": "Name",
    "部门": "Department",
    "职务": "Title",
    "职责": "Responsibility",
    "人员": "Personnel",
    "确认": "Confirm",
    "验证": "Verification",
    "试验": "Test",
    "分析": "Analysis",
    "报告": "Report",
    "计划": "Plan",
    "说明书": "Instruction Manual",
    "版本": "Version",
    "页码": "Page",
    "页": "Page",
    "共": "Total",
    "条": "Clause",
    "款": "Section",
    "项": "Item",
    "目": "Point",
    "注射笔": "Pen Injector",
    "自动注射笔": "Auto-Injector Pen",
    "罗星": "Luoxing",
    "灵秀路": "Lingxiu Road",
    "众利测绘": "Zhongli Surveying and Mapping",
    "恒温恒湿箱": "Constant Temperature and Humidity Chamber",
    "广州斯派克": "Guangzhou Spike",
    "仪器": "Instrument",
    "上海宝迈": "Shanghai Baomai",
    "装配": "Assembly",
    "上海磐云": "Shanghai Panyun",
    "技术": "Technology",
    "经治医生": "Attending Physician",
    "许可": "Permission",
    "任何更改": "Any changes",
    "必须得到": "must be obtained",
    "包装": "Packaging",
    "可能对": "may to",
    "请按": "Please follow",
    "规定": "regulations",
    "怕雨": "Keep Dry",
    "怕晒": "Keep away from sunlight",
    "功能": "Functional",
    "在": " in ",
    "视窗": "Window",
    "清楚": "Clear",
    "可辨识": "Legible",
    "以便": "in order to",
    "止退": "Backstop",
    "锁定力": "Locking Force",
    "药物": "Drug",
    "应是": "should be",
    "可见": "visible",
    "市": "City",
    "用": "Use",
    "未": "Not",
    "中": "In",
    "停用": "Discontinued",
    "状态": "Status",
    "塞": "Stopper",
    "屏蔽": "Shield",
    "通过": "Through",
    "方式": "Method",
    "显示": "Display",
    "提示音": "Prompt Sound",
    "距离": "Distance",
    "处": "Place",
    "测量": "Measure",
    "响度": "Loudness",
    "需": "Must",
    "倍": "Times",
    "注射按": "Injection Button",
    "与": "With",
    "接触": "Contact",
    "不被": "Not be",
    "看见": "Seen",
    "突出": "Protrude",
    "视觉": "Visual",
    "听觉": "Auditory",
    "触觉": "Tactile",
    "组合": "Combination",
    "废旧": "Used/Waste",
    "自动注射器": "Auto-Injector",
    "造成污染": "cause pollution",
    "高温": "High Temperature",
    "极低温": "Extreme Low Temperature",
    "潮湿": "Humidity",
    "灰尘": "Dust",
    "活动": "Activities",
    "两": "Two",
    "组成": "Composed of",
    "运输方式": "Transportation Method",
    "(下Same as Simject)": "(Hereinafter referred to as Simject)",
    "(下": "(Hereinafter ",
    "下": "Under", # Careful usage
    "Use in": "Used in",
    "Storeoruse": "Store or use",
    "provided": "provided",
    "Withmanufacturer": "With manufacturer",
    "有关规定": "relevant regulations",
    "回收": "recycle",
    "开始注射": "Start Injection",
    "怕雨": "Keep dry / Fear Rain",
    "怕晒": "Keep away from sunlight",
    "运输/贮存": "Transport/Storage",
    "患有心血管疾病": "suffering from cardiovascular disease",
    "脑血管疾病": "cerebrovascular disease",
    "代谢性疾病": "metabolic disease",
    "神经系统疾病": "nervous system disease",
    "正在服用": "are taking",
    "受体阻滞剂": "receptor blockers",
    "单胺氧化酶抑制剂": "monoamine oxidase inhibitors",
    "三环类抗抑郁药": "tricyclic antidepressants",
    "洋地黄类": "digitalis",
    "谨慎": "caution",
    "所有测试设备必须在校准期内": "All test equipment must be within the calibration period",
    "拟定申报有效期": "Proposed registration validity period",
    "适用 in": "applies to",
    "抛弃式": "disposable",
    "不与": "do not contact",
    "药液": "drug solution",
    "仅供": "only for",
    "单人单次": "single patient single",
    "急救": "first aid",
    "任何更改都必须得到": "Any changes must be obtained from",
    "经治医生": "attending physician",
    "许可": "permission",
    "相容": "compatible with",
    "预填充": "Pre-filled",
    "带有": "with",
    "针头": "needle",
    "系列": "series",
    "自由坠落试验": "Free Fall Test",
    "本研究": "This study",
    "结论": "conclusion",
    "支持": "supports",
    "pcs持": "supports", # Fix broken mapping
    "该半成品包装形式下": "under this semi-finished packaging form",
    "期间": "period",
    "器械": "device",
    "符合": "meet/comply with",
    "本说明书": "This instruction manual",
    "介绍了": "introduces",
    "如何": "How to",
    "故障": "Fault",
    "治疗方案": "treatment plan",
    "建议": "advice",
    "核心团队成员": "Core Team Members",
    "请参阅参与者名单": "Please refer to the Participant List",
    "参阅": "refer to",
    "参与者名单": "Participant List",
    "检验": "Inspection",
    "其中": "of which",
    "后组件": "rear component",
    "注射助推器": "injection booster",
    "由": "composed of",
    "注射器载体": "syringe carrier",
    "动力弹簧装置": "power spring mechanism",
    "运输储存": "Transport and Storage",
    "抢救紧急过敏反应": "rescue emergency allergic reactions",
    "过敏性休克": "anaphylactic shock",
    "哮喘": "asthma",
    "心脏骤停": "cardiac arrest",
    "恶劣": "harsh",
    "注射笔": "injection pen",
    "厂家": "manufacturer",
    "注册人": "Registrant",
    "搭配": "combined with",
    "肾上腺素注射液": "epinephrine injection",
    "药械": "drug-device",
    "相关": "relevant",
    "双方沟通": "both parties communicate",
    "部件": "Component",
    "制造商": "Manufacturer",
    "规格": "Specification",
    "件": "parts",
    "针管外直径": "Needle Outer Diameter",
    "针管内直径": "Needle Inner Diameter",
    "和": " and ", # Re-assert
    "  ": " ", # Double space cleanup
    "Serious性": "Severity", # Fix for mixed term in screenshot
    "性": "Nature/Property", # Fallback
    "Detection(D)to": "Detection (D) to",
    "Occurrence(O)、": "Occurrence (O), ",
    "Severity(S)": "Severity (S)",
    "Detection(D)": "Detection (D)",
    "foreseeable": "foreseeable", # Fix typo found in screenshot if present
    # Fixing Fragmentation from single-char mappings
    "物理性能": "Physical Properties",
    "潜在": "Potential",
    "毒性": "Toxicity",
    "致癌性": "Carcinogenicity",
    "致突变性": "Mutagenicity",
    "生殖毒性": "Reproductive Toxicity",
    "发育毒性": "Developmental Toxicity",
    "生殖": "Reproductive",
    "发育": "Developmental",
    "关注水平": "Level of Concern",
    "化学性质": "Chemical Properties",
    "接触类别": "Contact Category",
    "接触": "Contact",
    "存留潜能": "Potential for Retention",
    "体外循环": "Extracorporeal Circuit",
    "受益": "Benefit",
    "风险评价": "Risk Evaluation",
    "风险/受益": "Risk/Benefit",
    "安全使用史": "History of Safe Use",
    "粘膜": "Mucosa",
    "破裂": "Breached",
    "损伤": "Compromised",
    "外部接入": "Externally Communicating",
    "血路": "Blood Path",
    "间接": "Indirect",
    "组织/骨": "Tissue/Bone",
    "植入": "Implant",
    "生物学评定": "Biological Evaluation",
    "生物学评价": "Biological Evaluation",
    "已有文献": "Existing Literature",
    "论证": "Justification/Rationale",
    "建议": "Proposal/Advice",
    "豁免": "Exemption",
    "选择": "Selection",
    "终点": "Endpoint",
    "可提取物": "Extractables",
    "化学表征": "Chemical Characterization",
    "单一": "Single",
    "合金": "Alloy",
    "陶瓷": "Ceramic",
    "群体": "Population",
    "认证": "Certification",
    "足够": "Sufficient",
    "性质": "Properties",
    "Nature/Property": "Nature", # Cleanup if it leaked
    # Remaining Logic and Connectors
    "没有改变": "has not changed",
    "回答为": "Answer is",
    "回答": "Answer",
    "是": "Yes",
    "否": "No",
    "时": " when ",
    "见": "See",
    "之后": "afterwards",
    "是否": "Whether",
    "充分": "Sufficient",
    "毒理学数据": "Toxicological Data",
    "毒理学": "Toxicology",
    "化学混合物": "Chemical Mixture",
    "混合物": "Mixture",
    "途径": "Route",
    "相关": "Relevant",
    "金属": "Metal",
    "包含": "Contain",
    "关注水平": "Level of Concern",
    "水平": "Level",
    "且": " and ",
    "对": " for ", 
    "对于": "For",
    "进一步评价": "Further Evaluation",
    "进一步": "Further",
    "根据": "According to",
    "已有": "Existing",
    "数据": "Data",
    "因为": "Because",
    "所以": "Therefore",
    "判定": "Decision/Determination",
    "步骤": "Step",
    "建立": "Establish",
    "建立了": "Established",
    "史": "History",
    "物理": "Physical",
    "化学": "Chemical",
    "生物学": "Biological",
    "物质": "Substance",
    "致癌": "Carcinogenic",
    "致突变": "Mutagenic",
    "生殖": "Reproductive",
    "发育": "Developmental",
    "器官": "Organ",
    "体外": "In Vitro",
    "循环": "Circulation",
    "所有": "All",
    "该": "The",
    "Applies to in": "Applies to", # Correction
    "详见": "Refer to details in",
    "生产厂家": "Manufacturer",
}
# Signatory Mapping Backup (if not in TEAM_MEMBERS variable)
# But we will use the TEAM_MEMBERS logic principally.
